Figure 3 Life expectancy at birth in all countries included

Slides:

Advertisements

Similar presentations

Table 3 Limb-girdle muscular dystrophy standardized data collection form and HPO mapping Thompson, R. & Straub, V. et al. (2016) Limb-girdle muscular dystrophies.

Advertisements

Nat. Rev. Neurol. doi:10/1038/nrneurol

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol

Figure 1 Male infertility and assisted reproduction globally

Nat. Rev. Neurol. doi: /nrneurol

Figure 2 The US Centers for Disease Control and

Figure 4 Time course of the development of physiological changes

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol

with undiagnosed diabetes mellitus by three diagnostic criteria

Figure 1 Carotid artery inflammation detected using 18F-FDG-PET

Figure 1 Hypothetical staging model of sporadic Alzheimer disease (AD)

Nat. Rev. Neurol. doi: /nrneurol

Figure 2 Overview of risk factors for Parkinson disease dementia

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Urol. doi: /nrurol

Figure 3 Proportion of patients for whom NEDA

Figure 5 Number of AHSCT procedures for

Figure 2 Co-stimulatory receptors as immunomodulatory targets

Figure 1 Diagnostic tiers of Parkinson disease as single disease

Figure 1 Cost of one month of treatment with

Nat. Rev. Endocrinol. doi: /nrendo

Figure 2 Algorithm for immunosuppressive treatment

Nat. Rev. Neurol. doi: /nrneurol

Figure 1 Principles of therapeutic ultrasound

Figure 1 Cardiovascular risk and disease across the life-course

Nat. Rev. Neurol. doi: /nrneurol

Figure 1 Clinical correlates of neurodegeneration in MS

Figure 2 Median monthly launch price of a new anticancer drug,

Figure 3 Genetic pleiotropy in ALS

Nat. Rev. Neurol. doi: /nrneurol

Figure 1 Evolution of multiple sclerosis

Figure 2 Haemorrhagic stroke prevalence and mortality

Figure 1 The trajectory of cognitive ageing

in the UK (1961–2012), France (1961–2014) and Italy (1961–2010)

Nat. Rev. Neurol. doi: /nrneurol

Figure 3 Challenges for big data applications in cardiovascular care

Nat. Rev. Neurol. doi: /nrneurol

Figure 3 Stroke-related deaths and DALYs by country development status

Figure 2 Age-specific prevalence of common comorbidities

Nat. Rev. Neurol. doi: /nrneurol

Figure 2 Carotid artery inflammation detected using 68Ga-DOTATATE-PET

Figure 6 Combining population-wide and high-risk strategies

Figure 1 Ischaemic stroke prevalence and mortality

Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Cardiol. doi: /nrcardio

Figure 1 Frequency of vertigo and dizziness syndromes

Figure 2 Logistical requirements for autologous

Figure 3 Potential interplay between physiological

Nat. Rev. Neurol. doi: /nrneurol

Figure 1 The VEGF family of growth factors

Nat. Rev. Nephrol. doi: /nrneph

Figure 2 Cellular pathways implicated in CIPN

Figure 2 Pathophysiological mechanisms in LGMD

Nat. Rev. Neurol. doi: /nrneurol

Figure 1 Timing of the effects of deep brain stimulation

Figure 5 Interaction between infarction and amyloid deposition

Figure 1 A large number of genes are potentially associated with CIPN

Figure 1 Patient, facility, health-care system and industry factors

Nat. Rev. Cardiol. doi: /nrcardio

Figure 1 Overall worldwide prevalence ranges for SLE

Figure 3 Rett syndrome severity and age at diagnosis by mutation type

Nat. Rev. Neurol. doi: /nrneurol

Figure 2 Network connections of the hypothalamus

Presentation transcript:

Figure 3 Life expectancy at birth in all countries included in population-based studies of dementia incidence and prevalence Figure 3 | Life expectancy at birth in all countries included in population-based studies of dementia incidence and prevalence. Data obtained from from Gapminder, the National Center for Health Statistics, USA84 and Wu, Y.-T. et al.5. Wu, Y.-T. et al. (2017) The changing prevalence and incidence of dementia over time — current evidence Nat. Rev. Neurol. doi:10.1038/nrneurol.2017.63